CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 147 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2016. The put-call ratio across all filers is 1.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $797,000 | -75.6% | 210,807 | +1.2% | 0.40% | -70.6% |
| Q4 2015 | $3,267,000 | +44.0% | 208,343 | -3.2% | 1.37% | +22.1% |
| Q3 2015 | $2,268,000 | -51.5% | 215,137 | +16.1% | 1.12% | -49.1% |
| Q2 2015 | $4,674,000 | -0.8% | 185,333 | +9.6% | 2.20% | -8.6% |
| Q1 2015 | $4,714,000 | +68.1% | 169,145 | +10.1% | 2.41% | +51.5% |
| Q4 2014 | $2,804,000 | +51.5% | 153,617 | +7.6% | 1.59% | +25.5% |
| Q3 2014 | $1,851,000 | -18.6% | 142,811 | +2.5% | 1.27% | -17.4% |
| Q2 2014 | $2,274,000 | -2.9% | 139,355 | +5.1% | 1.53% | -7.7% |
| Q1 2014 | $2,342,000 | -16.7% | 132,548 | +14.2% | 1.66% | -30.4% |
| Q4 2013 | $2,811,000 | – | 116,096 | – | 2.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TSP Capital Management Group, LLC | 813,273 | $3,286,000 | 1.66% |
| RTW INVESTMENTS, LP | 1,243,164 | $5,022,000 | 1.52% |
| Marcus Capital, LLC | 112,200 | $453,000 | 0.44% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 996,178 | $4,024,000 | 0.29% |
| Benchmark Capital Advisors | 67,000 | $271,000 | 0.20% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 360,299 | $1,456,000 | 0.20% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 2,907,523 | $11,746,000 | 0.15% |
| Virtus ETF Advisers LLC | 59,537 | $241,000 | 0.12% |
| Bellevue Group AG | 160,000 | $646,000 | 0.12% |
| PDT Partners, LLC | 428,300 | $1,730,000 | 0.10% |